Prana Biotechnology Ltd (NASDAQ:PRAN)

Thursday’s Trading Day
1.17 +0.0599 / +5.40%
As of Feb 26
Day’s Change
Friday’s Pre-Market   Switch to standard view »
1.25 +0.0801 / +6.85%
Volume: 2.7K
Health Technology

Company Description

Prana Biotechnology Ltd. is focused on the research and development of treatments for Alzheimer's, Huntington's disease and other major age related degenerative disorders. It is developed a proprietary library of class chemical compounds, which is combined with a drug development program to explore novel therapeutics in multiple disease indications. The company was founded by Geoffrey Paul Kempler on November 11, 1997 and is headquartered in Parkville, Australia.

Contact Information

Prana Biotechnology Ltd.
369 Royal Parade
Parkville Victoria (vic) 3052
P:(139) 349-4906
Investor Relations:



Other institutional1.62%
Mutual fund holders0.02%
Individual stakeholders--

Top Executives

Geoffrey Paul KemplerExecutive Chairman & Chief Executive Officer
Dianne AngusChief Operating Officer

To view my watchlist

Not a member yet?

Sign up now for a free account